Patient Leaflet Updated 29-Sep-2020 | Glenmark Pharmaceuticals Europe Ltd
Nefopam hydrochloride 30 mg Film-coated Tablets
Nefopam Hydrochloride 30 mg Film-coated Tablets
1. What Nefopam hydrochloride is and what it is used for
2. What you need to know before you use Nefopam hydrochloride
3. How to use Nefopam hydrochloride
4. Possible side effects
5. How to store Nefopam hydrochloride
6. Contents of the pack and other information
The name of your medicine is Nefopam Hydrochloride 30 mg Film-coated Tablets (referred to as ‘Nefopam hydrochloride’ throughout this leaflet). Nefopam hydrochloride includes the active substance nefopam hydrochloride.
Nefopam hydrochloride belongs to a group of medicines called analgesics, commonly known as pain killers or pain relievers. It interrupts the pain messages being sent to your brain, and it also acts in your brain to stop pain messages being felt. This means that Nefopam hydrochloride does not stop the pain from happening, but you will not be able to feel the pain as much.
Nefopam hydrochloride is used to relieve acute and chronic pain (for example pain after an operation, dental pain, joint or muscle pain, after an injury, or pain caused by cancer).
Nefopam hydrochloride should not be used to treat the pain from a heart attack.
Talk to your doctor before using Nefopam hydrochloride if:
If any of the above apply to you, your doctor may decide to alter your treatment.
Children
Do not give this medicine to children between the ages of 0 to 12 years as the safety has not yet been established.
Do not take Nefopam hydrochloride if you are taking a medicine to treat your depression known as a monoamine oxidase inhibitor (MAOI).
Tell your doctor, dentist or pharmacist if you are taking or have recently taken the medicines listed below:
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Nefopam hydrochloride should not be taken during pregnancy or while breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Please contact your doctor if you become pregnant during your treatment.
Nefopam hydrochloride can cause drowsiness. Do not drive or operate heavy machinery unless you know how Nefopam hydrochloride affects you.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with you doctor or pharmacist if you are not sure.
The recommended dose is two tablets taken three times a day. Your doctor may increase this dose up to a maximum of three tablets taken three times a day, according to your needs.
Ask your doctor or pharmacist if:
How to take the tablets
The tablets are for oral use. They should be swallowed with a glass of water.
Use in children (under 12 years)
Nefopam hydrochloride should not be taken by children under 12 years.
Use in elderly patients
In older patients the doctor may reduce the number of tablets that are taken.
Use in patients with kidney and/or liver problems
Your doctor may adjust the dose of Nefopam hydrochloride depending upon your condition.
If you take more tablets than you should, tell your doctor or pharmacist immediately or contact your nearest hospital casualty department. Remember to take the pack and any remaining tablets with you.
If you forget to take Nefopam hydrochloride, take it as soon as you remember. Do not take a double dose to make up for a forgotten dose.
Do not stop taking Nefopam hydrochloride without first checking with your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking this medicine and contact your doctor immediately if you experience:
Other side effects include:
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
The active substance is nefopam hydrochloride 30 mg.
The other ingredients are calcium hydrogen phosphate dehydrate, microcrystalline cellulose, pregelatinised starch, colloidal anhydrous silica, magnesium stearate.
The coating material consists of hydroxypropyl methylcellulose, polyethylene glycol (6000 & 400) and titanium dioxide (E171).
Nefopam hydrochloride 30 mg film-coated tablets are white to off white, round, film-coated biconvex tablets engraved with “20” on one side and “G” on the other side.
The tablets are available in Alu-Alu blister packs containing 90 tablets.
This leaflet was last revised in September 2020
Building 2, Croxley Park, Watford, WD18 8YA
+44 (0)1923 251137
www.glenmarkpharma.com
+44 (0)1923 202 950
0800 458 0383
+44 (0)1923 202 950